NCT06261190View on ClinicalTrials.gov

Active Surveillance for Low-risk Papillary Thyroid Carcinoma

Enrolling by invitationOBSERVATIONAL
Enrollment

499

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2032

Conditions
Thyroid CancerPapillary Thyroid Carcinoma
Trial Locations (4)

Unknown

National Cancer Center, Goyang-si

Seoul National University Bundang Hospital, Seongnam

Seoul National University Hospital, Seoul

SMC-SNU Boramae Medical Center, Seoul

All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Seoul National University Hospital

OTHER

lead

National Cancer Center, Korea

OTHER_GOV